Search

everythinglearnresearchcommunity

for

Search:↓

The pandemic worsened mental health and healthcare access for middle-aged women, leading to negative changes in their lifestyle.

COVID-19 may cause hair loss due to infection stress or treatments.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Testosterone may influence COVID-19 severity and outcomes.

COVID-19 can cause various skin issues, including rashes and lesions.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

COVID-19 protective measures led to skin irritation, hair loss, and brittle nails; using skin-friendly products and a healthy diet is recommended.

COVID-19 can cause hair loss, loss of taste and smell, skin changes, and eye problems.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

No significant link between male pattern baldness and COVID-19 severity was found.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

The AndroCoV Clinical Scoring is a quick, accurate, and free tool for diagnosing COVID-19.

Nursing staff's mental health was affected during the COVID-19 pandemic.

Healthcare workers in Turkey experienced more skin problems due to frequent handwashing and wearing masks and gloves during the COVID-19 outbreak.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Passiflora incarnata may help with anxiety and sleep issues but has side effects; teleconsultation for heart failure can improve quality of life; increased screen time for children during the pandemic led to more clinical complaints; older and severely affected COVID-19 patients are more likely to have long-term symptoms.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.